Cancer often seems to strike out of the blue, without warning or reason and often without a clear cause. But in some cases, the cause of a cancer is very… Read More
Ovarian cancer is a tricky disease to treat. About 20 percent of those diagnosed don’t respond to the standard treatment, which means they lose precious time taking a treatment that… Read More
We’re all familiar with Facebook and Fitbit — they’re convenient technologies that make our lives a bit easier. But scientists at Seattle Children’s Research Institute are hoping those technologies could… Read More
As progress is being made against deadly infectious diseases in Africa and other parts of the developed world, a new killer is rearing its head: cancer. Cancer now kills more… Read More
Dr. Matthias Stephan has a vision: cancer-killing immunotherapy that is so cheap and easy to access it replaces chemotherapy as the front-line treatment for cancer. “What I envision is like the… Read More
At the Seattle Cancer Care Alliance’s Proton Therapy Center in North Seattle, the halls are rarely quiet. “You’ll hear ’80s music blaring,” said Dr. Ramesh Rengan, or “music that actually speaks of illness… Read More
A weird type of benign tumor has been discovered in an unlikely place: the fossilized jaw of a distant ancestor of present-day mammals that lived 255 million years ago. The… Read More
When Molly Lindquist was struck with breast cancer five years ago, it was a terrifying experience. And it was agonizingly frustrating. “You lose control of your body — my cells… Read More
Scientists at Seattle’s Fred Hutchinson Cancer Research Center have figured out how to use venom from the Israeli deathstalker scorpion to “light up” cancerous cells, making it easier for surgeons to distinguish them… Read More
If Seattle’s prestigious Fred Hutchinson Cancer Research Center is going to use cloud computing power to help eradicate cancer, then Matthew Trunnell — a soft-spoken Midwesterner and former carpenter — is… Read More
Microsoft researchers are doing a bug bash on cancer, complete with software code names like “Project Hanover.” Some of them are actually drilling down into our genetic code, looking for… Read More
Cancer researchers have to deal with some of nature’s ugliest diseases, but they do find bits of beauty along the way – and that beauty is the focus of an… Read More
Seattle-based Juno Therapeutics has acquired RedoxTherapies for $10 million, to secure exclusive rights to a molecule that may provide a new cancer treatment. The molecule, called vipadenant, may help the immune… Read More
Seattle-based Juno Therapeutics says it’s resuming a clinical trial of its immunotherapy treatment, a week after the Food and Drug Administration ordered a hold due to the deaths of three… Read More
The U.S. Food and Drug Administration placed a hold on a Juno Therapeutics clinical trial of a treatment for a form of leukemia following the death of two trial patients… Read More
In 1961, President John F. Kennedy asked Americans to rally around a lofty goal: Landing on the moon. Today, Vice President Joe Biden has his eyes on a different, but… Read More
Commercial partners can help non-profits, like the Fred Hutchinson Cancer Research Center, bring life-saving treatments to patients faster. That’s why the Hutch appointed “a scientific matchmaker” to connect scientists and businesses.… Read More
A quarter-century after her discovery of the BRCA1 breast cancer gene, University of Washington geneticist Mary-Claire King has received the nation’s highest scientific honor – and high praise from President Barack… Read More
Kiara, a patient at St. Jude Children’s Research Hospital, loves horses. She plays with toy horses, colors in horse coloring books, and wears a pink sweater with a big horse on… Read More
Less than a year since Vice President Joe Biden buried his son, who died from brain cancer, Biden is expected to continue talking up the White House’s cancer-fighting task force… Read More
NanoString Technologies, a Seattle-based company that researches how genetic and immune markers can be used to predict patient response to different cancer therapies, announced today that it will join pharmaceutical… Read More
Despite posting record sales of its cancer drug and beating analyst expectations for its fourth quarter earnings on Tuesday, shares of Seattle Genetics are down 7 percent today. Seattle Genetics… Read More
One of the giants of gene sequencing, Illumina, has spun off a new $100 million company called Grail to create an all-in-one blood test for cancer – and its investors include… Read More
One of the most popular sessions at the recent GeekWire Summit was a talk by Dr. Jim Olson, cancer researcher and serial entrepreneur, attending physician at Seattle Children’s Hospital, University of Washington… Read More
The granddaughter of genetic pioneer Francis Crick joined 20 other artists to create a series of 7-foot-high sculptures inspired by DNA’s double helix – and now those sculptures are going on… Read More
Researchers from Seattle who are finding ways to eliminate cancer are bringing in some serious funding today. On the same day the Fred Hutchinson Cancer Research Center announced a $20 million donation… Read More
One big problem with existing cancer therapies available today like chemotherapy and radiation is the collateral damage. While some medicine can completely kill cancer, it also may destroy healthy, normal… Read More
Marking a milestone in the fight against cancer, Seattle Children’s Research Institute this afternoon reported that the first patient in a closely watched clinical trial has had a positive response… Read More
Dr. Rebecca Gardner and her colleagues at Seattle Children’s Research Institute are altering the body’s infection-fighting blood cells to attack cancer in the same way those cells fight viruses. The… Read More
The American Cancer Society estimates that about 30 percent of cancer deaths are tied to poor nutrition, lack of exercise and obesity. Now, the Fred Hutchinson Cancer Research Center has… Read More